Viatris Inc. VTRS

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

$19.63

Close on Fri, 20 Nov 2026 · market value $22.5B

What the price is betting on

Below its record

At $20, the price assumes revenue shrinks about 6.6% a year for five years, from $14.7B to about $11B by FY2030. That is less than what analysts expect for the next two years and about the same as the company's own last three years.

The price assumes−6.6%
Analysts, next two years3.5%
Last 3 years−1.7%

Revenue growth a year. The price figure comes from a reverse DCF at a 8.6% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than VTRS? Check up to 5 of your stocks at once, free, no account.

0$5B$10B$15B$20B$14.7B'22'23'24'25Sep '26'26'27'28'29'30What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$30

Base

$34

Bull

$38

Today $20

  • Bear $30. Cash flow grows 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $34. Cash flow grows 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $38. Cash flow grows 6% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$14.5B$14.8B, on the path
  3. FY2027$13.5B$15.5B, on the path
  4. FY2028$12.6B$15.9B, on the path
  5. FY2029$11.8B$16.1B, on the path
  6. FY2030$11B$16.9B, on the path

Each year's revenue at −6.6% growth from $14.7B in the 12 months to September 2026.

At a glance

Healthcare · Drug Manufacturers - Specialty & Generic · listed on NASDAQ

Revenue, FY2025
$14.3B
Growth, 3 years a year
−1.7%
Cash margin
14%
Net debt
$13.2B
Shares, 3-year change
−3.8%
Dividend yield
2.5%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.